輸入代號或公司名稱後按 Enter
SIGA

SIGA TECHNOLOGIES INC

-0.04 (-1.29%)前一交易日收盤 2026-09-17
美股 · Nasdaq · 製藥生技 · 製藥SIC 2834
3.06USD322K成交股數220M市值本益比(近四季)4.1股價營收比-49.5%營收年增(近四季)2026-11-05下次財報

財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束

逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。

營收與利潤率近 16 季

稀釋 EPS近 16 季 · 美元

現金流近 16 季

股東回饋近 16 季 · 庫藏股與股利

損益表 逐季 · 最新在左 · 小字是年增率

科目26Q226Q125Q425Q325Q225Q124Q324Q224Q123Q423Q323Q2
營收41.0M-49%6.2M-11%3.8M-62%2.6M-88%81.1M+219%7.0M-94%10.0M+8%21.8M+271%25.4M116M9.2M5.9M
營業成本17.6M2.9M3.0M1.0M25.6M158K1.6M12.3M3.2M14.8M897K974K
毛利23.4M-58%3.3M-52%804K-90%1.6M-83%55.6M+150%6.9M-93%8.4M+1%9.5M+94%22.2M102M8.3M4.9M
毛利率57.2%52.9%21.2%61.8%68.5%97.8%83.8%43.6%87.3%87.3%90.3%83.4%
研發費用4.4M3.9M5.0M7.1M4.4M3.5M3.0M2.9M3.1M2.6M3.6M5.1M
銷售管理費用5.1M4.7M5.3M4.8M5.5M5.7M4.8M5.5M7.9M7.4M6.0M4.4M
營業利益13.9M-70%−5.3M+136%−9.5M-1852%−10.2M-1047%45.7M+305%−2.3M-102%542K-141%1.1M-123%11.3M91.7M−1.3M−4.6M
營業利益率33.9%-85.2%-250.4%-390.2%56.3%-32.0%5.4%5.0%44.3%78.7%-14.2%-78.9%
稅後淨利12.5M-65%−3.5M+746%−5.4M-504%−6.4M-447%35.5M+245%−408K-101%1.3M-442%1.8M-164%10.3M72.3M−393K−2.9M
淨利率30.4%-55.3%-143.1%-243.0%43.7%-5.8%13.4%8.4%40.4%62.0%-4.3%-48.9%
稀釋 EPS0.17-65%-0.05+400%-0.07-450%-0.09-400%0.49+250%-0.01-101%0.02-300%0.03-175%0.141.01-0.01-0.04
稀釋股數71.9M71.6M71.9M71.6M71.7M71.4M71.8M71.8M71.6M71.7M71.1M71.1M

資產負債表 期末餘額

科目26Q226Q125Q425Q325Q225Q124Q324Q224Q123Q423Q323Q2
現金與約當現金118M146M155M172M182M162M99.3M107M144M150M71.1M76.2M
應收帳款7.2M4.5M3.3M2.5M6.5M7.2M12.1M9.0M18.1M21.1M8.1M6.0M
存貨41.1M56.5M49.1M48.0M35.6M59.1M62.0M55.7M63.7M64.2M65.0M50.5M
總資產176M219M219M232M235M247M195M193M243M254M158M147M
有息負債
總負債10.4M67.8M20.6M28.1M26.0M30.9M25.9M25.1M78.2M57.5M34.2M22.4M
股東權益165M152M199M203M209M216M169M168M165M197M124M124M
負債比5.9%30.9%9.4%12.1%11.1%12.5%13.3%13.0%32.1%22.6%21.6%15.3%
淨現金(現金 − 有息負債)

現金流量表 單季

科目26Q226Q125Q425Q325Q225Q124Q324Q224Q123Q423Q323Q2
營業現金流−8.7M-223%7.1M−6.1M
資本支出025K0
自由現金流−8.7M-223%7.0M−6.1M
折舊攤銷150K135K138K
買回庫藏股0
現金股利159K0
自由現金流率-138.8%99.9%-24.1%

營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度

地區2025 年度 · 100M
美國88.8M88.4%-23.3%
加拿大5.8M5.8%+689.1%
美國以外5.8M5.8%-74.7%
產品/服務2025 年度 · 94.6M
Product Sales And Supportive Services88.0M93.1%-34.0%
Research And Development6.5M6.9%+21.1%

各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。

年度 10-K

財年營收年增稅後淨利淨利率稀釋 EPS自由現金流
FY202594.6M-31.8%23.3M24.6%0.3243.1M
FY2024139M-0.9%59.2M42.7%0.8248.7M
FY2023140M+26.3%68.1M48.6%0.9594.8M
FY2022111M-17.1%33.9M30.6%0.4641.6M
FY2021134M+7.0%69.5M52.0%0.9111.4M
FY2020125M+367.3%56.3M45.1%0.7171.5M
FY201926.7M-94.4%−7.2M-27.1%-0.15−18.2M
FY2018477M422M88.4%5.1868.8M